Cargando…
Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity
Recent studies have shown that mutations at amino-acid 482 in the ABCG2 gene affect the substrate specificity of the protein. To delineate the effects of these mutations clearly, human embryonic kidney cells (HEK-293) were stably transfected with wild-type 482R or mutant 482G and 482T ABCG2. By flow...
Autores principales: | Robey, R W, Honjo, Y, Morisaki, K, Nadjem, T A, Runge, S, Risbood, M, Poruchynsky, M S, Bates, S E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394461/ https://www.ncbi.nlm.nih.gov/pubmed/14612912 http://dx.doi.org/10.1038/sj.bjc.6601370 |
Ejemplares similares
-
hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations
por: Wang, F, et al.
Publicado: (2010) -
Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer
por: Suzuki, H, et al.
Publicado: (2008) -
The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas
por: Caldwell, G M, et al.
Publicado: (2006) -
Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk
por: Lindmark, F, et al.
Publicado: (2005) -
Synergistic and antagonistic drug interactions in the treatment of systemic fungal infections
por: Wambaugh, Morgan A, et al.
Publicado: (2020)